Restricted accessResearch articleFirst published online 2018-08
Associations Between MTR A2756G,MTRR A66G,and TCN2 C776G Polymorphisms and Risk of Nonsyndromic Cleft Lip With or Without Cleft Palate: A Meta-Analysis
We conducted a meta-analysis to investigate the associations of methionine synthase (MTR) A2756G, methionine synthase reductase (MTRR) A66G, and transcobalamin 2 (TCN2) C776G gene polymorphisms with nonsyndromic cleft lip with or without cleft palate (NSCL/P).
Materials and Methods:
The PubMed, Web of Science, Embase, and Wiley Online Library databases and the China Biomedical Literature Service System (SinoMed) were searched for relevant articles to explore the associations between the MTR A2756G, MTRR A66G, and TCN2 C776G polymorphisms and the risk of NSCL/P. We performed overall comparisons and stratified analyses according to the ethnicity, type of NSCL/P, and Hardy-Weinberg equilibrium (HWE) of the control group. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were applied to estimate the associations of these gene polymorphisms with NSCL/P risk using fixed-effects or random-effects models incorporating five genetic models.
Results:
Ultimately, 12 articles were included in this study. The pooled results did not reveal a significant association of the MTR A2756G polymorphism with NSCL/P risk (G vs. A: OR = 0.95, 95% CI = 0.82-1.11, p = 0.55). Similar results were observed for the MTRR A66G polymorphism (G vs. A: OR = 0.99, 95% CI = 0.82-1.18, p = 0.72) and the TCN2 C776G polymorphism (G vs. C: OR = 0.95, 95% CI = 0.86-1.06, p = 0.37).
Conclusion:
In summary, the MTR A2756G, MTRR A66G, and TCN2 C776G polymorphisms might not be associated with NSCL/P risk.
Get full access to this article
View all access options for this article.
References
1.
AşlarD, HakkıT (2014) Prevalence of MTHFR, MTR and MTRR gene polymorphisms in Turkish patients with nonsyndromic cleft lip and palate. Gene Ther Mol Biol, 16:115-129.
2.
BadovinacRL, WerlerMM, WilliamsPL, et al. (2007) Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol, 79:8-15.
3.
BezerraJF, OliveiraGH, SoaresCD, et al. (2015) Genetic and non-genetic factors that increase the risk of non-syndromic cleft lip and/or palate development. Oral Dis, 21:393-399.
4.
BhaskarLV, MurthyJ, Venkatesh BabuG (2011) Polymorphisms in genes involved in folate metabolism and orofacial clefts. Arch Oral Biol, 56:723-737.
5.
BrandalizeAP, BandinelliE, BorbaJB, et al. (2007) Polymorphisms in genes MTHFR, MTR and MTRR are not risk factors for cleft lip/palate in South Brazil. Braz J Med Biol Res, 40:787-791.
6.
CaiB, ZhangT, ZhongR, et al. (2014) Genetic variant in MTRR, but not MTR, is associated with risk of congenital heart disease: an integrated meta-analysis. PLoS One, 9:e89609.
ChenLH, LiuML, Hwang HY et al. (1997) Human methionine synthase. cDNA cloning, gene localization, and expression. J Biol Chem, 272:3628-3634.
9.
CobourneMT (2004) The complex genetics of cleft lip and palate. Eur J Orthod, 26:7-16.
10.
de ArrudaIT, PersuhnDC, de OliveiraNF (2013) The MTHFR C677T polymorphism and global DNA methylation in oral epithelial cells. Genet Mol Biol, 36:490-493.
11.
GueantJL, ChabiNW, Gueant-RodriguezRM, et al. (2007) Environmental influence on the worldwide prevalence of a 776C->G variant in the transcobalamin gene (TCN2). J Med Genet, 44:363-367.
12.
GunnerbeckA, Edstedt BonamyAK, WikstromAK, et al. (2014) Maternal snuff use and smoking and the risk of oral cleft malformations—a population-based cohort study. PLoS One, 9:e84715.
13.
HanD, ShenC, MengX, et al. (2012) Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies. Mol Biol Rep, 39:805-816.
14.
HerrmannW, SchorrH, ObeidR, et al. (2003) Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. Am J Clin Nutr, 78:131-136.
15.
HuY, ChenEJ, ChenRJ, et al. (2011) Association of TCN2 gene with non-syndromic cleft lip with or without cleft palate. Beijing J Stomatol, 19:4-7.
16.
JiaZL, ShiB, ChenCH, et al. (2011) Maternal malnutrition, environmental exposure during pregnancy and the risk of non-syndromic orofacial clefts. Oral Dis, 17:584-589.
17.
JinLL, ChenEJ, HouW, et al. (2015) The Association between folate pathway genes and cleft lip with or without cleft palate in a Chinese population. Biomed Environ Sci, 28:136-139.
18.
LeclercD, CampeauE, GoyetteP, et al. (1996) Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet, 5:1867-1874.
19.
LeclercD, WilsonA, DumasR, et al. (1998) Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci U S A, 95:3059-3064.
20.
LiYN, GulatiS, BakerPJ, et al. (1996) Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet, 5:1851-1858.
21.
MangoldE, LudwigKU, NothenMM (2011) Breakthroughs in the genetics of orofacial clefting. Trends Mol Med, 17:725-733.
22.
MartinelliM, ScapoliL, PalmieriA, et al. (2006) Study of four genes belonging to the folate pathway: transcobalamin 2 is involved in the onset of non-syndromic cleft lip with or without cleft palate. Hum Mutat, 27:294.
23.
MosseyPA, LittleJ, MungerRG, et al. (2009) Cleft lip and palate. Lancet, 374:1773-1785.
24.
MosseyPA, ModellB (2012) Epidemiology of oral clefts 2012: an international perspective. Front Oral Biol, 16:1-18.
25.
MostowskaA, HozyaszKK, JagodzinskiPP (2006) Maternal MTR genotype contributes to the risk of non-syndromic cleft lip and palate in the Polish population. Clin Genet, 69:512-517.
26.
MostowskaA, HozyaszKK, WojcickiP, et al. (2010) Associations of folate and choline metabolism gene polymorphisms with orofacial clefts. J Med Genet, 47:809-815.
27.
MurthyJ, GurramkondaVB, LakkakulaBVKS (2015) Genetic variant in MTRR A66G, but not MTR A2756G, is associated with risk of non-syndromic cleft lip and palate in Indian population. J Oral Maxillofac Surg Med Pathol, 27:782-785.
28.
NamourF, OlivierJ, AbdelmouttalebI, et al. (2001) Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood. Blood, 97:1092-1098.
29.
OlteanuH, BanerjeeR (2001) Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. J Biol Chem, 276:35558-35563.
30.
PanY, ZhangW, MaJ, et al. (2012) Infants' MTHFR polymorphisms and nonsyndromic orofacial clefts susceptibility: a meta-analysis based on 17 case-control studies. Am J Med Genet A, 158a:2162-2169.
31.
PlatekME, ShieldsPG, MarianC, et al. (2009) Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev, 18:2453-2459.
32.
PrescottNJ, MalcolmS (2002) Folate and the face: evaluating the evidence for the influence of folate genes on craniofacial development. Cleft Palate Craniofac J, 39:327-331.
33.
RougetF, MonfortC, BahuauM, et al. (2005) Periconceptional folates and the prevention of orofacial clefts: role of dietary intakes in France. Revue d'epidemiologie et de sante publique, 53:351-360.
34.
Waltrick-ZambuzziM, TannurePN, VieiraTC, et al. (2015) Genetic variants in folate and cobalamin metabolism-related genes in nonsyndromic cleft lip and/or palate. Braz Dent J, 26:561-565.
35.
WangJB, NanXR (2011) Association between Rs1805087 polymorphisms of MTR gene and non-syndromic cleft lip with or without cleft palate. Beijing J Stomatol, 19:88-91.
36.
WangW, JiaoXH, WangXP, et al. (2016) MTR, MTRR, and MTHFR gene polymorphisms and susceptibility to nonsyndromic cleft lip with or without cleft palate. Genet Test Mol Biomarkers, 20:297-303.
37.
WehbyGL, GocoN, Moretti-FerreiraD, et al. (2012) Oral cleft prevention program (OCPP). BMC Pediatr, 12:184.
38.
WehbyGL, MurrayJC. (2010) Folic acid and orofacial clefts: a review of the evidence. Oral Dis, 16:11-19.
39.
WilsonA, PlattR, WuQ, et al. (1999) A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metabol, 67:317-323.
40.
WongWY, EskesTK, Kuijpers-JagtmanAM, et al. (1999) Nonsyndromic orofacial clefts: association with maternal hyperhomocysteinemia. Teratology, 60:253-257.
41.
WuT, FallinMD, ShiM, et al. (2012) Evidence of gene-environment interaction for the RUNX2 gene and environmental tobacco smoke in controlling the risk of cleft lip with/without cleft palate. Birth Defects Res A Clin Mol Teratol, 94:76-83.
42.
YuanGH, NanXR (2013) Association between polymorphism of MTR rs1805087 locus and nonsyndromic cleft lip with or without cleft palate. J Oral Maxillofac Surg, 23:248-252.
43.
YuanQ, BlantonSH, HechtJT (2011) Genetic causes of nonsyndromic cleft lip with or without cleft palate. Adv Otorhinolaryngol, 70:107-113.
44.
ZhangT, LouJ, ZhongR, et al. (2013) Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature. PLoS One, 8:e59570.
45.
ZhaoM, RenY, ShenL, et al. (2014) Association between MTHFR C677T and A1298C polymorphisms and NSCL/P risk in Asians: a meta-analysis. PLoS One, 9:e88242.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
